Patho+Pharm Exam 1 Drugs

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

27 Terms

1
New cards
  • More common 

  • Affect nails and mucous membranes 

    • Moist areas (ex. Feet enclosed in shoes) 

  • Treated with topical agents 

  • Deeper infections (scalp and nails) may require oral systemic antifungal therapy

Superficial

2
New cards
  • Affect internal organs (typically lungs, brain, digestive organs) 

    • Need very specific antifungal treatments 

  • Are less common 

  • Can be fatal in immunosuppressed patients, who’re more at risk

  • Treated with oral or parenteral agents

Systemic

3
New cards
  • fungal infection systemic

  • Opportunistic: happens in immunocompromised ppl

  • People usually asymptomatic

  • Aspergillosis 

  • Opportunistic 

  • Most commonly affects the lungs but can spread to other organs

Aspergillus fumigatus and other species

4
New cards
  • fungal infection systemic

  • Blastomycosis 

  • Begins in the lungs and spreads to other organs 

    • Caused by breathing in spores (lungs)

    • Can be asymptomatic but also lead to RBS (respiratory distress syndrome)

Blastomyces dermatitidis

5
New cards
  • fungal infection systemic

  • Candidiasis 

Most common opportunistic fungal infection (ex. Yeast infection), and may affect nearly any organ

Candida albicans and other species

6
New cards
  • fungal infection systemic

  • Coccidioidomycosis 

  • Begins in the lungs and spreads to other organs

    • Dangerous and possibly life threatening 

  • Also found in soil but can be breathed in by spores

  • Rare but can be dangerous/life threatening 

Coccidioides immitis (aka Valley fever)

7
New cards
  • fungal infection systemic

  • Cryptococcosis 

  • Opportunistic (immunocompromised pts) 

  • Begins in the lungs, but is the most common cause of meningitis in patients with AIDS 

    • Caused by breathing in spores

Cryptococcus neoformans

8
New cards
  • fungal infection systemic

  • Histoplasmosis 

  • Begins in the lungs and spreads to other organs 

  • Also found in soil, bird droppings, bat droppings

    • In health hx, we must remember to ask how they got this?

Histoplasma capsulatum

9
New cards
  • fungal infection systemic

  • Pneumocystis pneumonia 

  • Opportunistic 

    • Immunocompromised hosts 

  • primarily causes pneumonia of the lung but can spread to other organs

Pneumocystis jiroveci

10
New cards
  • fungal infections superficial

  • Candidiasis 

  • Affects the skin, nails, oral cavity (thrush), vagina

Candida albicans and other species

11
New cards
  • fungal infections superficial

  • Athlete's foot (tinea pedis), jock itch (tinea cruris), and other skin disorders

Epidermophyton floccosum

12
New cards
  • fungal infections superficial

  • Ringworm of the scalp (tinea capitis) 

    • These organisms feed on the keratin in our skin

Microsporum species

13
New cards
  • fungal infections superficial

  • Sporotrichosis: primarily affects the skin and superficial lymph nodes 

    • Aka Rose gardener’s disease

    • Thorns on roses can cause microcuts 

    • Spores found in soil which can come into contact with cut

Sporothrix schenckii

14
New cards
  • fungal infections superficial

  • Affects the scalp, skin, and nails 

  • Causes skin rash

Trichophyton species

15
New cards

A fungal infection of the scalp

tinea capitis

16
New cards

A fungal infection of the unguium/onychomycosis

nails

17
New cards

A fungal infection of the corporis

trunk

18
New cards

A fungal infection of the manus

ring shaped patch; usually on hands

19
New cards

A fungal infection of the pedis

feet

20
New cards

A fungal infection of the cruris

usually groin area

21
New cards

A fungal infection of the thrush

white layer around mouth, tongue, cheeks

22
New cards
  • Toenail fungal infections

  • PO medication (by mouth); systemic treatment for superficial fungal infection 

  • MOA: Fungicidal activity 

    • Inhibits action of enzymes squalene epoxidase 

    • Causes cell death by destroying the enzyme (which will destroy cell wall) 

  • Classification: Antifungal-allylamine 

  • Primary use: onychomycosis 

  • Adverse effects: headache, dermatitis, Gi distress, taste disturbances, and liver enzyme abnormalities (rare) 

  • Nursing considerations: 

    • Treatment is for many weeks 

    • Baseline LFTs (liver function test), monitoring 

    • Inhibitor of CYP2D6

      • This enzyme helps with liver metabolism; its inhibition causes difficulty in drug metabolism of all drugs (including any meds the pt is taking)

      • Leads to higher drug concentration

Commonly used: terbinafine (Lamisil) PO

23
New cards
  • Topical Infections

  • MOA: increases keratin resistance to fungal invasion 

    • After absorption, medication is deposited in keratin precursor cells

    • Prevents fungal invasions in areas of high keratin; infected keratin sheds and is replaced by fungus free tissue

    • Affects mitosis of fungi, preventing fungi from growing 

  • Classification: Antifungal-allylamine 

  • Primary use: tinea capitis; onychomycosis 

  • Adverse effects: headache, nausea, vomiting, diarrhea, photosensitivity (sensitivity to light) 

  • Nursing considerations: 

    • Advise patients to abstain from ETOH (alcohol)

    • Contraindicated with liver failure 

      • Pts with liver failure should not be given this!! 

      • Many drug to drug interactions

    • Administer with fatty meal for improved absorption

    • Not for use in pregnancy or lactation 

      • Category X; most dangerous for pregnant women 

    • Many drug-drug interactions

Commonly used: griseofulvin PO

24
New cards
  • superficial infections

  • Polyinhibitor 

  • MOA: binds to sterols in the fungal cell membrane, allowing leakage of intracellular contents 

    • Destroys cell membranes

  • Classification: Antifungal-polyene 

  • Primary use: Candida infections of intestines, vagina, skin, mouth 

  • Adverse effects: minor skin irritation, nausea, vomiting, diarrhea 

  • Nursing considerations: 

    •  For oral candidiasis (thrush), apply with a swab to the affected area in infants and children because swishing is difficult or impossible.

      • Have to swab it for them 

    • For adults with oral candidiasis (thrush), the drug should be swished in the mouth for at least 2 minutes.

      • Similar to mouth wash 

Commonly used: nystatin (Mycostatin) top, PO

25
New cards
  • systemic infections

  • Very strong, very serious, lifesaving medication 

  • Drug of choice for systemic mycoses

  • Also polyinhibitor 

  • Very little is known on its excretion; can stay in body system for very long time

  • MOA: binds to ergosterol in fungal cell membranes; causes them to become permeable or leaky 

    • Disrupts outer cell membrane; becomes antifungal 

  • Classification: Antifungal-systemic polyene 

  • Effective against: Candida sp, Cryptococcus, Aspergillus sp.-**Used in life threatening infections** 

    • Effective against most fungal infections but only should be used for life threatening infections

  • Adverse effects: fever, chills, vomiting, headache; serious: hypotension (low BP), dysrhythmias; nephrotoxicity (damage to kidneys); phlebitis (inflammation of vein) 

  • Nursing considerations: 

    • Not for use in renal failure; strict monitoring of electrolytes 

      • b/c nephrotoxic 

    • Monitor IV site of infusion diligently-phlebitis common 

      • Can cause inflammation of the vein 

    • Infuse slowly because cardiovascular collapse may result if the medication is infused too rapidly.

    • Administer premedication, such as acetaminophen, antihistamines, and corticosteroids, to decrease the risk of hypersensitivity 

reactions


Commonly used: amphotericin B (Fungizone) IV

26
New cards
  • systemic infections

  • Yeast infections, etc

  • Usually one time dose

  • Topical = athletes foot, etc

  • MOA: to act by interfering with synthesis of ergosterol; inhibit 14 alpha-demethylase 

    • Affects cell membrane 

    • Broad spectrum so affects many fungal species but much lower toxicity 

  • Classification: Antifungal Azole 

  • Primary use: to treat fungal infections in CNS, bone, eyes, urinary tract, respiratory tract 

  • Adverse effects: nausea, vomiting, diarrhea reported at high doses, some hepatotoxicity

    •  toxicity to the liver b/c it inhibits of CYP enzyme → raising levels of other drugs 

  • Nursing considerations: 

    • Used cautiously in patients with CKD (chronic kidney disease)

      • b/c of excretion 

    • Monitor blood sugar with concurrent use with oral hypoglycemic

      • Can decrease blood sugar levels  

    • Many drug-drug interactions

      • Other drug levels can be raised again b/c of CYP enzyme inhibition 

    • Usually not given in hospital but to pt at home

      • Make sure to educate pt and ask about any other meds they are taking 

Commonly used: fluconazole (Diflucan); itraconazole (Sporanox), ketoconazole (Nizoral) (PO/topical), clotrimazole (topical, vaginal)

27
New cards
  • antiprotozoal medications

  • ex) malaria, trichomoniasis, etc. 

  • Safe to take outpatient

  • Antibiotic properties; effective against some bacteria

    • MOA: disrupts nucleic acid synthesis; has antiprotozoal and antibiotic activity 

    • Classification: Anti-infective, anti-protozoan 

    • Primary use: trichomoniasis, respiratory, bone, skin infections; H. pylori PUD and PMC and Crohn’s disease 

    • Adverse effects: anorexia, nausea, diarrhea, dizziness, headache, dry mouth, unpleasant metallic taste; dark urine 

    • Nursing considerations: 

      • Contraindicated in first trimester of pregnancy 

      • Advise patients to not drink alcohol ETOH (ETOH = ethanol) while taking this medication

      • Caution with immunosuppressed patient

  • Commonly used: metronidazole (Flagyl), PO, IV